ALT in the 13F filings
Altimmune Inc · CUSIP 02155H200
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 10 Feb 2026
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 1 listed it in both
- Shares listed
- 10,654,731
- combined, among listed positions
- Reported value
- $38m
- combined, at the quarter end
Among the 92 comparable managers: 14 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,042,963.
Managers listing ALT in Q4 2025
24 of 24 holders
Largest increases and reductions, by shares
Increases
- Jane Street Group LLCexisting position · 1,783,950 shares now+1,503,751
- D. E. Shaw & Co.existing position · 1,343,583 shares now+983,188
- Marshall Wace LLPnew position · 922,777 shares now+922,777
- Fidelity (FMR LLC)existing position · 564,093 shares now+118,956
- Balyasny Asset Management LLCnew position · 60,109 shares now+60,109
Reductions
- Two Sigma Investments LPexisting position · 1,265,683 shares now-731,165
- Two Sigma Advisers LPexisting position · 793,900 shares now-634,500
- Squarepoint Ops LLCexisting position · 34,949 shares now-549,747
- ExodusPoint Capital Management LPexisting position · 11,921 shares now-166,256
- Millennium Management LLCexisting position · 207,383 shares now-160,199
New positions and exits
New (6)
Exited (1)
- Point72 Asset Management LPwas $1.8m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2020 | 1 | $8.4m | n.a. | n.a. |
| Q3 2020 | 1 | $952k | n.a. | n.a. |
| Q2 2021 | 1 | $15m | n.a. | n.a. |
| Q3 2021 | 1 | $3.9m | n.a. | n.a. |
| Q4 2021 | 2 | $6.8m | n.a. | n.a. |
| Q1 2022 | 2 | $5.9m | n.a. | n.a. |
| Q2 2022 | 2 | $8.0m | n.a. | n.a. |
| Q3 2022 | 4 | $89m | n.a. | n.a. |
| Q4 2022 | 5 | $133m | n.a. | n.a. |
| Q4 2023 | 1 | $382k | 1 | 0 |
| Q1 2024 | 2 | $7.0m | 2 | 0 |
| Q2 2024 | 1 | $184k | 0 | 1 |
| Q3 2024 | 1 | $169k | 0 | 0 |
| Q4 2024 | 1 | $199k | 0 | 0 |
| Q1 2025 | 1 | $138k | 0 | 0 |
| Q2 2025 | 1 | $107k | 0 | 0 |
| Q3 2025 | 1 | $104k | 0 | 0 |
| Q4 2025 | 1 | $100k | 14 | 9 |
| Q1 2026 | 1 | $85k | 10 | 12 |
| Q2 2026 | 1 | $20m | 20 | 7 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ALT and LLY →ALT and JNJ →ALT and VRTX →Choose a stock to compare with ALT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ALT, latest filings →Back to the 13F Explorer →